PRESS RELEASE published on 09/18/2024 at 12:05, 1 year 7 months ago Rapport semestriel au 30 juin 2024
BRIEF published on 09/16/2024 at 11:22, 1 year 7 months ago La Banque Palatine introduit Palatine Avenir 2030, un titre de créance à risque Investissement Marché Actions Banque Palatine Titre De Créance Risque De Capital
BRIEF published on 09/16/2024 at 11:22, 1 year 7 months ago Banque Palatine introduces Palatine Avenir 2030, a risky debt security Investment Stock Market Palatine Bank Debt Security Capital Risk
PRESS RELEASE published on 09/16/2024 at 11:17, 1 year 7 months ago Informations privilégiées / Autres communiqués La Banque Palatine lance Palatine Avenir 2030, un titre de créance à risque. Détails financiers et modalités de souscription inclus Souscription Banque Palatine Titre De Créance Palatine Avenir 2030 Risque
BRIEF published on 09/12/2024 at 10:50, 1 year 7 months ago Disponibilité des Final Terms de l'émission série 579 tranche 1 par la BFCM Investisseurs Final Terms Crédit Mutuel BFCM Émission Série 579
BRIEF published on 09/12/2024 at 10:50, 1 year 7 months ago Availability of the Final Terms of the 579 series issue tranche 1 by BFCM Investors Final Terms Crédit Mutuel BFCM Series 579 Broadcast
PRESS RELEASE published on 09/12/2024 at 10:45, 1 year 7 months ago BFCM Communiqué de mise à disposition des Final Terms de l’émission série 579 tranche 1 La Banque Fédérative du Crédit Mutuel communique les modalités de disponibilité des Final Terms de l’émission séries 579 tranche 1. Les documents sont accessibles sur le site de l’émetteur Final Terms Modalités Émission Document BFCM
BRIEF published on 09/12/2024 at 08:42, 1 year 7 months ago Sanofi, RadioMedix, and Orano Med Announce Exclusive Licensing Agreement for Radioligand Therapy Sanofi RadioMedix Orano Med AlphaMedix Neuroendocrine Tumors
BRIEF published on 09/12/2024 at 08:42, 1 year 7 months ago Sanofi, RadioMedix et Orano Med annoncent un accord de licence exclusif pour la thérapie par radioligand Sanofi Orano Med AlphaMedix Radio Médix Tumeurs Neuroendocrines
Published on 05/09/2026 at 01:30, 2 days 3 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 days 5 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 13 hours 23 minutes ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 15 hours 28 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 17 hours 43 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day 10 hours ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 2 days 8 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 3 days 10 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 10 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 10 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 10 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 10 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
